Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$48.72 - $61.12 $633 - $794
13 Added 18.31%
84 $4,000
Q2 2022

Aug 15, 2022

SELL
$52.06 - $58.9 $416 - $471
-8 Reduced 10.13%
71 $4,000
Q1 2022

May 10, 2022

SELL
$52.94 - $61.88 $423 - $495
-8 Reduced 9.2%
79 $4,000
Q3 2021

Nov 15, 2021

SELL
$51.0 - $60.54 $306 - $363
-6 Reduced 6.45%
87 $5,000
Q2 2021

Aug 13, 2021

SELL
$42.92 - $53.03 $858 - $1,060
-20 Reduced 17.7%
93 $5,000
Q1 2021

May 13, 2021

SELL
$36.16 - $47.63 $976 - $1,286
-27 Reduced 19.29%
113 $5,000
Q4 2020

Feb 08, 2021

BUY
$32.69 - $37.69 $1,863 - $2,148
57 Added 68.67%
140 $5,000
Q3 2020

Nov 06, 2020

BUY
$34.54 - $40.79 $1,174 - $1,386
34 Added 69.39%
83 $3,000
Q2 2020

Jul 15, 2020

BUY
$36.63 - $44.07 $1,794 - $2,159
49 New
49 $2,000

Others Institutions Holding PBH

About Prestige Consumer Healthcare Inc.


  • Ticker PBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,762,600
  • Market Cap $3.77B
  • Description
  • Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...
More about PBH
Track This Portfolio

Track Howe & Rusling Inc Portfolio

Follow Howe & Rusling Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.